Annual Operating Expenses
$46.54 M
-$7.69 M-14.18%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual total operating expenses is $46.54 million, with the most recent change of -$7.69 million (-14.18%) on December 31, 2023.
- During the last 3 years, LVTX annual operating expenses has risen by +$28.12 million (+152.66%).
- LVTX annual operating expenses is now -14.18% below its all-time high of $54.23 million, reached on December 31, 2022.
Performance
LVTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$11.29 M
+$1.92 M+20.55%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly total operating expenses is $11.29 million, with the most recent change of +$1.92 million (+20.55%) on September 30, 2024.
- Over the past year, LVTX quarterly operating expenses has increased by +$515.00 thousand (+4.78%).
- LVTX quarterly operating expenses is now -44.79% below its all-time high of $20.44 million, reached on March 31, 2021.
Performance
LVTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LVTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | +4.8% |
| 3 y3 years | +152.7% | +4.8% |
| 5 y5 years | +385.6% | +4.8% |
LVTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | at low | -33.0% | +100.0% |
| 5 y | 5-year | -14.2% | +385.6% | -44.8% | +182.9% |
| alltime | all time | -14.2% | +385.6% | -44.8% | +182.9% |
LAVA Therapeutics NV Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.29 M(+20.6%) |
| Jun 2024 | - | $9.36 M(+4.7%) |
| Mar 2024 | - | $8.94 M(+58.6%) |
| Dec 2023 | $46.54 M(-14.2%) | $5.64 M(-47.6%) |
| Sep 2023 | - | $10.77 M(-33.9%) |
| Jun 2023 | - | $16.30 M(+17.8%) |
| Mar 2023 | - | $13.83 M(-2.0%) |
| Dec 2022 | $54.23 M | $14.12 M(-16.1%) |
| Sep 2022 | - | $16.83 M(+45.8%) |
| Jun 2022 | - | $11.54 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.73 M(+12.8%) |
| Dec 2021 | $48.96 M(+165.8%) | $10.40 M(-0.6%) |
| Sep 2021 | - | $10.46 M(+36.6%) |
| Jun 2021 | - | $7.66 M(-62.5%) |
| Mar 2021 | - | $20.44 M(+297.9%) |
| Dec 2020 | $18.42 M(+92.2%) | $5.14 M(+10.7%) |
| Sep 2020 | - | $4.64 M(+10.1%) |
| Jun 2020 | - | $4.21 M(+5.6%) |
| Mar 2020 | - | $3.99 M |
| Dec 2019 | $9.58 M | - |
FAQ
- What is LAVA Therapeutics NV annual total operating expenses?
- What is the all time high annual operating expenses for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual operating expenses year-on-year change?
- What is LAVA Therapeutics NV quarterly total operating expenses?
- What is the all time high quarterly operating expenses for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly operating expenses year-on-year change?
What is LAVA Therapeutics NV annual total operating expenses?
The current annual operating expenses of LVTX is $46.54 M
What is the all time high annual operating expenses for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual total operating expenses is $54.23 M
What is LAVA Therapeutics NV annual operating expenses year-on-year change?
Over the past year, LVTX annual total operating expenses has changed by -$7.69 M (-14.18%)
What is LAVA Therapeutics NV quarterly total operating expenses?
The current quarterly operating expenses of LVTX is $11.29 M
What is the all time high quarterly operating expenses for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly total operating expenses is $20.44 M
What is LAVA Therapeutics NV quarterly operating expenses year-on-year change?
Over the past year, LVTX quarterly total operating expenses has changed by +$515.00 K (+4.78%)